FDA - Food and Drug Administration

10/07/2024 | Press release | Distributed by Public on 10/07/2024 13:35

Philips Respironics (Trilogy Evo, Trilogy Evo O2, Trilogy Evo Universal, and Trilogy EV300 ventilators/Philips Respironics, Inc.) Recall reason: The use of in-line nebulizers[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.